UNSPSC 85815702: Introduction of other hormone into central vein, percutaneous approach
Commodity
Code facts
- Part of
-
-
85000000
-
85810000
- 85815700
-
85810000
-
85000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 85815702
Definition
This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other hormone into central vein, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E043VJ
About UNSPSC 85815702
UNSPSC 85815702 Introduction of other hormone into central vein, percutaneous approach is a Commodity code that sits at odds with recent state and local procurement activity tagged under this medical-procedure classification. The recent opportunities demonstrate that state and local health systems are actually soliciting for telehealth urgent care, PACE operations, occupational health services, cancer registry services, retinal screening devices, employee wellness platforms, and medical directorship roles—none of which align with the narrow clinical procedure named in the code. The issuing bodies span county health authorities (Nevada Health Authority, San Mateo County, Santa Clara County), county departments and sheriff's offices (DeKalb County, Boulder County, Brevard County, Sarasota County), municipal health systems and retirement offices (City of Phoenix, City of Ocala), school districts (Parkway School District), and specialized state agencies. Geographic spread includes California, Georgia, Florida, Nevada, Colorado, Illinois, New Jersey, New York, Ohio, Arizona, Kansas, and Texas, with no single state dominating activity.
The code shows little relevant recent activity under its nominal scope. Representative recent opportunities in the block address services substantially disconnected from percutaneous hormone infusion: Inland Empire Health Plan's RFI for 24/7/365 virtual urgent care (RFI 2607426, due October 31, 2026), the Nevada Health Authority's RFP for PACE operations (RFP 41NHA-S4038, due December 10, 2026), San Mateo County's RFP for cancer registry services (RFP 660002627262, due October 12, 2026), and the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RFP RTMRFP26001, due October 16, 2026). This code appears to be a miscellaneous catch-all or data-entry artifact in state and local procurement systems rather than a live procurement category. Buyers pursuing state and local health-related opportunities should verify the actual service scope against the code classification in each RFP and cross-reference with clinical service or operational support codes that better reflect what is actually being bought.
Quick answers
What is UNSPSC 85815702?
UNSPSC 85815702 is Introduction of other hormone into central vein, percutaneous approach, a commodity in UNSPSC 85000000, Healthcare Services.
Which NIGP codes match UNSPSC 85815702?
UNSPSC 85815702 maps to 1 NIGP code, 94848 Health Care Services (Not Otherwise Classified).
On GovTribe
See everything under UNSPSC 85815702
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code